The U.S. microbial fermentation technology market size was estimated at USD 7.22 billion in 2023 and is expected to grow at a CAGR of 5.12% from 2024 to 2030. Microbial fermentation plays a vital role in bio-production, influencing cost and quality. The burgeoning biopharmaceutical secto... Read More »
April 2024The U.S. computational biology market was valued at USD 2.54 billion in 2023 and is expected to grow at a CAGR of 13.1% from 2024 to 2030. The discoveries in genomics, molecular biology, cellular & tissue engineering, bio-imaging & new drug discovery, and delivery techniques are ... Read More »
April 2024The U.S. research antibodies market size was estimated at USD 559.14 million in 2023 and is expected to grow CAGR of 4.0% from 2024 to 2030. The steady rise in research and development (R&D) activities, led by biopharmaceutical and pharmaceutical companies and paired with increased p... Read More »
April 2024The U.S. vitrification market size was estimated at USD 1.74 billion in 2023 and is expected to grow CAGR of 16.08% from 2024 to 2030, driven by factors such as changing sociodemographic aspects, increased infertility cases, and advanced fertility preservation techniques like IVF. Oocyte... Read More »
April 2024The U.S. tissue engineering market size was estimated at USD 8.1 billion in 2023 and is expected to grow at a CAGR of 13.4% from 2024 to 2030. The primary driver of this growth is the escalating demand for pioneering tissue engineering solutions that can treat chronic diseases and aid in... Read More »
April 2024The U.S. antisense and RNAi therapeutics market size was estimated at USD 2.76 billion in 2023 and is expected to grow at a CAGR of 19.10% from 2024 to 2030. Multidisciplinary applications of antisense technology in various diseases, growing cancer prevalence, and favorable government in... Read More »
April 2024The U.S. biotechnology instruments market was valued at USD 34.66 billion in 2023 and is expected to grow at a CAGR of 3.45% from 2024 to 2030 which can be attributed to the high demand and affordability of biotechnology instrumentation. Moreover, inclination toward manual automation in ... Read More »
April 2024The U.S. biomaterials market size was estimated at USD 59.3 billion in 2023 and is expected to grow at a CAGR of 14.8% from 2024 to 2030. The surge in the need for biomaterials is tied to an increase in accidental injuries and a higher incidence of chronic diseases. Moreover, the interest in innovative biomaterials ... Read More »
April 2024The U.S. biotechnology market size was estimated at USD 552.40 billion in 2023 and is expected to grow at a CAGR of 12.4% from 2024 to 2030. Government support plays a major role in propelling market growth, focusing on modernizing regulatory frameworks, enhancing approval processes and ... Read More »
April 2024The U.S. circulating tumor cells market size was estimated at USD 4.45 billion in 2023 and is expected to grow at a CAGR of 12.77% from 2024 to 2030. Some key drivers are increased awareness of cancer treatment and improved healthcare facilities. Technological developments, in ... Read More »
April 2024The U.S. genome editing market size was estimated at USD 3.49 billion in 2023 and is expected to grow at a CAGR of 16.5% from 2024 to 2030. The growth in the genome editing market is driven by rising demand for synthetic genes, the application of CRISPR technology, and government funding... Read More »
April 2024The U.S. genotyping market size was estimated at USD 6.42 billion in 2023 and is expected to grow at a CAGR of 13.7% from 2024 to 2030. Rising prevalence of genetic disorders & cancer, technological advancements, increased focus on developing personalized medicine, and increasing R&a... Read More »
April 2024The U.S. 3D cell culture market size was valued at USD 564.2 million in 2023 and is expected to grow at a CAGR of 11.0% from 2024 to 2030. The growth of the market is attributable to increasing availability of funding programs for research and development of potential alternatives for an... Read More »
April 2024The U.S. Cell therapy market size was valued at USD 2.66 billion in 2023 and is anticipated to grow at a CAGR of 21.18% from 2024 to 2030. Major factors contributing to this growth include the growing adoption of regenerative medicine, the rising number of clinical trials on cell therapi... Read More »
April 2024The U.S. exosomes market size was estimated at USD 73.58 million in 2023 and is expected to grow at a CAGR of 34.20% from 2024 to 2030. Exosome applications are advancing, which is driving market growth. Technological advancements in exosome isolation and analytical procedures are contri... Read More »
April 2024The Middle East stem cell market size was estimated at USD 694.0 million in 2023 and is projected to witness a CAGR of 7.56% from 2024 to 2030. The market’s growth can be attributed to the rising prevalence of chronic diseases such as cardiovascular diseases, and cancer. Growing aw... Read More »
March 2024The U.S. Cell and gene therapy manufacturing market was valued at USD 3.89 billion in 2023. It is anticipated to experience a CAGR of 27.1% from 2024 to 2030. Advanced therapies have significantly impacted the treatment of numerous rare and life-threatening diseases and revolutionized th... Read More »
March 2024The U.S. stem cells market size was estimated at USD 4.79 billion in 2023 and is expected to grow at a CAGR of 9.5% from 2024 to 2030. Increase in acceptance of regenerative medicine and rise in number of regulatory approvals of stem cell therapies are expected to drive the market. Growi... Read More »
March 2024The U.S. protein labeling market size was estimated at USD 932.2 million in 2023 and is expected to grow at a CAGR of 8.09% from 2024 to 2030. The key growth factors include the development of high-throughput proteomics platforms, advancements in mass spectrometry, and the integration of... Read More »
March 2024The U.S. gene synthesis market size was estimated at USD 691.1 million in 2023 and is expected to grow at a CAGR of 16.0% from 2024 to 2030. The market growth is significantly influenced by the presence of several key market participants offering gene synthesis services and increasing in... Read More »
March 2024